Automotive Anti-Pinch Power Window System Market to Reach $3,611.2 Million by 2023     |    Orthodontic Supplies Market to Reach $5.9 Billion by 2023     |    Automotive HMI Market to Reach $39,695 Million by 2023
P&S Market Research - A market research firm

DNA Diagnostics Market

P&S Market Research-DNA Diagnostics Market report

Global DNA Diagnostics Market Size, Share, Development, Growth and Demand Forecast to 2023

Delivery : 24-72 Working Hours
Report Code: LS10600
Available Format: pdf
Category : Biotechnology

The global DNA diagnostics market is growing due to technological advancement, and cost effective diagnostic solution. The growing adoption of new technologies such as polymerase chain reaction, next generation sequencing, and microarray is also posing an opportunity for the global market. Among the various products, the instrument segment leads the market, due to improved healthcare facilities, and its inexpensive cost structure. However, the services and software segment is expected to grow with the fastest rate during the forecast period. Among the various technologies, the PCR segment accounted for the largest share in the global market of DNA diagnostics, due to its frequent usage in diagnostic procedures, such as sample separation, isolation, and preparation of the DNA sample. And among the various applications, the oncology segment dominated the market of DNA diagnostic, due to increasing prevalence of chronic diseases and growing geriatric population.

The unexplored market in the DNA diagnostics industry of the developing economies is creating abundant growth opportunities for the global market. The product launches, and collaborations and partnerships are some of the major trends witnessed in the global market. DNA diagnosis technique helps healthcare professionals to identify various chronic and infectious diseases, such as cancer, hepatitis, tuberculosis and human immunodeficiency virus (HIV) accurately and cost effectively.

Some of the factors driving the growth of the global DNA diagnostics market are growing prevalence of chronic and infectious diseases, increasing adoption of personalized medicine, improving healthcare infrastructure in developing countries, and growing geriatric population. In addition, the increasing research and development in the field of biotechnology, increasing healthcare expenditure, and increasing demand for prenatal screening and new born testing are also fueling the growth of the global market. However, the high cost involved in research and development, strict regulatory requirement and lack of reimbursement policies are some of the factors, restraining the growth of the global DNA diagnostics market.

Geographically, North America is expected to dominate the global market during the forecast period, due to increasing prevalence of chronic and infectious diseases, and increasing adoption of DNA diagnostics technology. In addition, the refined healthcare infrastructure, and strong government initiatives and funding for DNA testing are also fueling the growth of the North American market. Asia-Pacific is expected to be the fastest growing region during the forecast period, due to increasing healthcare expenditure, and large pool of undiagnosed patients in the region. In addition, the Asia-Pacific market is growing due to increasing awareness about healthcare and improving healthcare infrastructure in the emerging countries, such as India and China.

Some of the companies operating in the global DNA diagnostics market are Sysmex Corporation, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Bayer Diagnostic, Illumina Inc., Gen-Probe Inc., Cephide Inc., Johnson and Johnson, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., and Novartis AG.

Global DNA Diagnostics Market Segmentation
By Product Type

  • Instruments
  • Reagents
  • Software and Services

By Technology

  • Polymerase Chain Reaction (PCR)
  • In situ Hybridization
  • Microarrays
  • Mass Spectrometry
  • Sequencing Technology
  • Others

By Application

  • Oncology
  • Infectious Disease Testing
  • Myogenic Disorder Diagnosis
  • Clinical Diagnosis Confirmation
  • Pre-implantation Diagnosis
  • Prenatal Diagnosis
  • Others

By End User

  • Point of Care
  • Central Laboratories or Diagnostic Centers
  • Self-testing

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
  • Asia-Pacific
    • Japan
    • China
    • India
  • Rest of the World

Place An Order

Single User License

Single User License authorizes access of the publication to single user, i.e. the buyer of the report.

Group License

Group License authorizes access of the publication upto 5 users.

Enterprise License

Enterprise License provides right to distribute copies of the publication across the organization and its subsidiaries.


Pre-Purchase Enquiry


Contact Us

  • U.S. Center : 347 5th Ave. #1402- 210 New York City, NY 10016 United States
  • Asian Center : B-28, Sector 1, Noida, U.P. - 201301 India.

Secure Online Payments

  • Payment